US Patent 7731977 Use of a botulinum neurotoxin to alleviate various disorders

Patent 7731977 was granted and assigned to Allergan, Inc. on June, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Allergan, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77319770

Patent Inventor Names

Alan H. Ackerman0

Date of Patent

June 8, 2010

Patent Application Number

120203740

Date Filed

January 25, 2008

Patent Primary Examiner

‌

S. Devi

Patent abstract

Methods for treating obsessions and compulsions by local administration of a Clostridial toxin. The obsessions or compulsions can be eye poking, body rocking, finger biting, counting, checking and related disorders treated by low dose, intramuscular administration of a botulinum toxin.